237 related articles for article (PubMed ID: 28614415)
1. Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.
Sekula P; Mallett S; Altman DG; Sauerbrei W
PLoS One; 2017; 12(6):e0178531. PubMed ID: 28614415
[TBL] [Abstract][Full Text] [Related]
2. Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.
Mallett S; Timmer A; Sauerbrei W; Altman DG
Br J Cancer; 2010 Jan; 102(1):173-80. PubMed ID: 19997101
[TBL] [Abstract][Full Text] [Related]
3. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.
Altman DG; McShane LM; Sauerbrei W; Taube SE
PLoS Med; 2012; 9(5):e1001216. PubMed ID: 22675273
[TBL] [Abstract][Full Text] [Related]
4. A Survey of the Prevalence and Impact of Reporting Guideline Endorsement in Pathology Journals.
Caron JE; March JK; Cohen MB; Schmidt RL
Am J Clin Pathol; 2017 Oct; 148(4):314-322. PubMed ID: 28967948
[TBL] [Abstract][Full Text] [Related]
5. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.
Sauerbrei W; Taube SE; McShane LM; Cavenagh MM; Altman DG
J Natl Cancer Inst; 2018 Aug; 110(8):803-811. PubMed ID: 29873743
[TBL] [Abstract][Full Text] [Related]
6. Reporting guidelines for health research: protocol for a cross-sectional analysis of the EQUATOR Network Library.
Catalá-López F; Alonso-Arroyo A; Page MJ; Hutton B; Ridao M; Tabarés-Seisdedos R; Aleixandre-Benavent R; Moher D
BMJ Open; 2019 Mar; 9(3):e022769. PubMed ID: 30837245
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic (STARD) and prognostic (REMARK) studies].
Altman DG; Bossuyt PM; ;
Med Clin (Barc); 2005 Dec; 125 Suppl 1():49-55. PubMed ID: 16464428
[TBL] [Abstract][Full Text] [Related]
8. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
[TBL] [Abstract][Full Text] [Related]
9. Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review.
Stevens A; Shamseer L; Weinstein E; Yazdi F; Turner L; Thielman J; Altman DG; Hirst A; Hoey J; Palepu A; Schulz KF; Moher D
BMJ; 2014 Jun; 348():g3804. PubMed ID: 24965222
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Reporting guidelines: doing better for readers.
Moher D
BMC Med; 2018 Dec; 16(1):233. PubMed ID: 30545364
[TBL] [Abstract][Full Text] [Related]
12. Structured reporting to improve transparency of analyses in prognostic marker studies.
Sauerbrei W; Haeussler T; Balmford J; Huebner M
BMC Med; 2022 May; 20(1):184. PubMed ID: 35546237
[TBL] [Abstract][Full Text] [Related]
13. Reporting quality of N-of-1 trials published between 1985 and 2013: a systematic review.
Li J; Gao W; Punja S; Ma B; Vohra S; Duan N; Gabler N; Yang K; Kravitz RL
J Clin Epidemiol; 2016 Aug; 76():57-64. PubMed ID: 26769257
[TBL] [Abstract][Full Text] [Related]
14. Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.
Jankova L; Dent OF; Molloy MP; Chan C; Chapuis PH; Howell VM; Clarke SJ
Proteomics Clin Appl; 2015 Dec; 9(11-12):1078-86. PubMed ID: 25755195
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Interventions to improve adherence to reporting guidelines in health research: a scoping review protocol.
Blanco D; Kirkham JJ; Altman DG; Moher D; Boutron I; Cobo E
BMJ Open; 2017 Nov; 7(11):e017551. PubMed ID: 29150467
[TBL] [Abstract][Full Text] [Related]
17. Results of a longitudinal study of rigorous manuscript submission guidelines designed to improve the quality of clinical research reporting in a peer-reviewed surgical journal.
Wynne KE; Simpson BJ; Berman L; Rangel SJ; Grosfeld JL; Moss RL
J Pediatr Surg; 2011 Jan; 46(1):131-7. PubMed ID: 21238654
[TBL] [Abstract][Full Text] [Related]
18. Reporting guidelines of health research studies are frequently used inappropriately.
Caulley L; Catalá-López F; Whelan J; Khoury M; Ferraro J; Cheng W; Husereau D; Altman DG; Moher D
J Clin Epidemiol; 2020 Jun; 122():87-94. PubMed ID: 32184126
[TBL] [Abstract][Full Text] [Related]
19. REporting recommendations for tumour MARKer prognostic studies (REMARK).
McShane LM; Altman DG; Sauerbrei W; Taube SE; Gion M; Clark GM;
Eur J Cancer; 2005 Aug; 41(12):1690-6. PubMed ID: 16043346
[TBL] [Abstract][Full Text] [Related]
20. Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST).
Launay E; Cohen JF; Bossuyt PM; Buekens P; Deeks J; Dye T; Feltbower R; Ferrari A; Kramer M; Leeflang M; Moher D; Moons KG; von Elm E; Ravaud P; Chalumeau M
BMC Med; 2016 Sep; 14(1):146. PubMed ID: 27677259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
